Saturday, February 21, 2026
21.7 C
Bengaluru

Great Opportunity for Pharma People to Listen to What Doctors have to Say

An insightful and informative Q&A session with Dr. Tejal Lathia, on the challenges of medical practice in Covid19 times…

Telemedicine has become an important tool for doctors to connect with patients.

Digital therapeutics will play an important role in managing chronic conditions.

Specialists are well informed in terms of new and emerging developments in a specialty like endocrinology, it is physicians and doctors in smaller towns that need regular updation.

Patients are better informed now – no point in discouraging them – let them Google, doctors must understand their concerns and point them to reliable sources of health related information.

Instead of insisting that Medical Reps meet doctors during #covid19​, pharma companies can help with concierge services in the management of people with diabetes…

Brand reminders do not serve any useful purpose, they only impair the relationship with doctors…

Now on MedicinMan YouTube Channel https://youtu.be/wqCK574qb-g

Brought to you by Digital Excellence Pharma Academy – A joint initiative of CredoWeb and MedicinMan

You can register on www.credoweb.in and watch over 50+ webinars and Q&A sessions with pharma leaders from India and overseas.

https://www.credoweb.in/discussion/500/selling-in-the-new-normal-the-rise-of-med-rep-20

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img